Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Patient-reported Outcome Measure Assessment and Circulating Tumor-DNA to Detect Early Relapse During Surveillance in Women With Vulva Cancer

NCT06495554 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06495554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Patient-reported Outcome Measure Assessment and Circulating Tumor-DNA to Detect Early Relapse During Surveillance in Women With Vulva Cancer
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Recruiting
Start date
August 15, 2024
Completion date
December 31, 2030
Enrollment
1,295 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, prom, survivorship, vulva cancer, vulva disease, vulva neoplasm, vulvar cancer, vulvar diseases, vulvar neoplasms